Kestra Advisory Services LLC Grows Stock Holdings in iShares Biotechnology ETF $IBB

Kestra Advisory Services LLC grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 47,461 shares of the financial services provider’s stock after acquiring an additional 5,155 shares during the period. Kestra Advisory Services LLC owned about 0.10% of iShares Biotechnology ETF worth $8,014,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 2nd quarter worth approximately $25,000. Basepoint Wealth LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $26,000. Cary Street Partners Financial LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $29,000. Copia Wealth Management bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Finally, Caitlin John LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $34,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $189.58 on Tuesday. iShares Biotechnology ETF has a 12-month low of $128.84 and a 12-month high of $199.05. The company’s fifty day simple moving average is $176.32 and its two-hundred day simple moving average is $172.93.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.